Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

‘Fundamental for all patients’: Exploring the benefits of palliative care for stroke survivors
Approximately 800,000 strokes occur each year in the United States alone. A majority of people survive, due in part to key advances in patient care over the years, but they often go forward without receiving the long-term help they need to recover and thrive.
Advancing AI for vascular surgery will require a commitment to data integrity
For artificial intelligence to truly transform care, the healthcare industry must address certain challenges. Jens Eldrup-Jorgensen, MD, a veteran vascular surgeon and member of the Society for Vascular Surgery, explains in a guest editorial.
Industry concerns over paclitaxel-coated devices may have put PAD patients at risk
Back in 2019, the FDA issued a warning about the use of paclitaxel-coated devices when treating peripheral artery disease. The agency took back that warning in 2023, but it appears to have made a significant impact on patient care.
Genetic predisposition to depression increases CVD risk in women, but not men
The heightened risks were even seen in women who were never diagnosed with a psychiatric disorder. It remains unclear why the same trend was not seen in men.
Clopidogrel vs. aspirin: Tracking the chronic maintenance period after PCI for different risk groups
As more high-risk patients undergo PCI, what is the best antiplatelet strategy following an initial event-free period of DAPT? Does it change after complex PCI? Researchers aimed to answer these questions, and many others, with new findings published in JAMA Cardiology.

Reperfusion suffers with in-hospital delays before stroke thrombectomy

Although the 2018 U.S. stroke guidelines recommended extending the window for endovascular thrombectomy (EVT) to 24 hours in select stroke patients, a new meta-analysis in JAMA Neurology serves as a reminder that prompt treatment remains crucial for achieving successful reperfusion.

January 24, 2019

Aspirin’s benefit in primary CVD prevention countered by bleeding risks

Aspirin offers modest protection against cardiovascular events in primary prevention, but that benefit is at least partially offset by an increase in major bleeding events, according to a meta-analysis published Jan. 22 in JAMA.

January 23, 2019

5-year data show no link between paclitaxel dose and mortality with Medtronic DCB

Medtronic hopes newly presented five-year survival data put to rest any concerns about the long-term safety of the company’s IN.PACT Admiral drug-coated balloon (DCB).

January 22, 2019

FDA to evaluate potential risks of paclitaxel-coated devices for PAD

The FDA is looking into the signal of increased late mortality associated with paclitaxel-coated balloons and stents that was observed in a recent meta-analysis of patients treated for femoropopliteal artery disease.

January 17, 2019

Researchers ID risk factors for VTE in large-scale study

Older age, smoking and a higher body mass index (BMI) were consistently associated with a heightened risk of venous thromboembolism (VTE) in an analysis of 1.1 million individuals published in JAMA Cardiology.

January 17, 2019

PTSD—especially from terror attacks—has lasting cardiovascular consequences

Long-term sufferers of post-traumatic stress disorder (PTSD) are at a higher risk for circulatory and metabolic diseases, especially if they’re men, according to research out of Siena, Italy.

January 15, 2019

Companies back paclitaxel-coated devices after unfavorable study

Executives from Medtronic and Boston Scientific stood behind their companies’ paclitaxel-coated medical devices after a meta-analysis published in the Journal of the American Heart Association in December linked balloons and stents covered with the material to a significantly increased risk of death at two and five years of follow-up.

January 14, 2019

Does telestroke participation improve hospitals’ clinical outcomes?

Participating in telemedicine for ischemic stroke care could modestly lower a hospital’s rate of tissue-type plasminogen activator (tPA)-related complications and in-hospital mortality, researchers reported in Circulation: Cardiovascular Quality and Outcomes.

January 11, 2019

Vascular & Endovascular

‘Fundamental for all patients’: Exploring the benefits of palliative care for stroke survivors

Advancing AI for vascular surgery will require a commitment to data integrity

Industry concerns over paclitaxel-coated devices may have put PAD patients at risk

Genetic predisposition to depression increases CVD risk in women, but not men

Clopidogrel vs. aspirin: Tracking the chronic maintenance period after PCI for different risk groups